Frontiers in Clinical Neuroscience: Neurodegeneration and Neuroprotection A Symposium in Abel Lajtha's Honour / Edition 1

Frontiers in Clinical Neuroscience: Neurodegeneration and Neuroprotection A Symposium in Abel Lajtha's Honour / Edition 1

by Laszlo Vecsei
ISBN-10:
0306480387
ISBN-13:
9780306480386
Pub. Date:
11/30/2003
Publisher:
Springer US
ISBN-10:
0306480387
ISBN-13:
9780306480386
Pub. Date:
11/30/2003
Publisher:
Springer US
Frontiers in Clinical Neuroscience: Neurodegeneration and Neuroprotection A Symposium in Abel Lajtha's Honour / Edition 1

Frontiers in Clinical Neuroscience: Neurodegeneration and Neuroprotection A Symposium in Abel Lajtha's Honour / Edition 1

by Laszlo Vecsei
$109.99
Current price is , Original price is $109.99. You
$109.99 
  • SHIP THIS ITEM
    Qualifies for Free Shipping
  • PICK UP IN STORE
    Check Availability at Nearby Stores

Overview

This is a special proceedings - "Frontiers in Clinical Neuroscience: 2002" - held in Abel Lajtha's honor. Professor Lajtha is a well-known supporter of Hungarian science and he is celebrating his 80th birthday this year. Professor Vecsei is the secretary for the European Society for Clinical Neuropharmacology and the Danube Symposium for Neurological Sciences. The proceedings will focus on neurodegeneration and neuroprotection, two current topics in clinical and experimental neuroscience.


Product Details

ISBN-13: 9780306480386
Publisher: Springer US
Publication date: 11/30/2003
Series: Advances in Experimental Medicine and Biology , #541
Edition description: 2004
Pages: 195
Product dimensions: 6.10(w) x 9.25(h) x 0.24(d)

Table of Contents

Advances in Neuroprotection Research for Neurodegenerative Diseases.- Neurotransmitter Release in Experimental Stroke Models: The Role of Glutamate-GABA Interaction.- Neuroprotection in Ischemic/Hypoxic Disorders: From the Preclinical to the Clinical Testing.- Neuroprotection and Dopamine Agonists.- COMT Inhibition in the Treatment of Parkinson’s Disease: Neuroprotection and Future Perspectives.- Neuroprotection and Epilepsy.- Neuroprotection and Glatiramer Acetate: The Possible Role in the Treatment of Multiple Sclerosis.- Causes and Consequences of Disturbances of Cerebral Glucose Metabolism in Sporadic Alzheimer Disease: Therapeutic Implications.- Neuroprotection: A Realistic Goal for Aged Brain?.- Kynurenines in Neurodegenerative Disorders: Therapeutic Consideration.
From the B&N Reads Blog

Customer Reviews